Heidbreder Christian
Chief Scientific Officer
Heidbreder Christian has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 13, 2026.
On the most recent filing, Heidbreder Christian is listed as Chief Scientific Officer at Indivior Pharmaceuticals, Inc. Inside the rolling window, Heidbreder Christian reported no open-market purchases and 2 open-market sales totaling $1.5M in INDV. The largest disclosed transaction in the window is a sale of 18,586 INDV shares on Jul 10, 2026, worth $765K.
Companies traded
Other insiders at INDV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Heidbreder Christian made?
Heidbreder Christian has filed 4 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Heidbreder Christian trade?
Heidbreder Christian has filed SEC Form 4 disclosures for 1 company, including INDV.
When was Heidbreder Christian's most recent SEC Form 4 filing?
Heidbreder Christian's most recent SEC Form 4 filing on Tracefour is dated Jul 13, 2026.
What is Heidbreder Christian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Heidbreder Christian is listed as Chief Scientific Officer.
What is Heidbreder Christian's total buy and sell value in the current window?
Inside the rolling retention window, Heidbreder Christian bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Heidbreder Christian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,586 INDV shares on 2026-07-10, worth $765K, per SEC Form 4 filings.